InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
17,060.40
(
0.00%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.28
(
0.07%
)
Bitcoin
64,350.03
(
0.11%
)
Post# of 1721
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BottomBounce

Send PM Follow Ignore
Followers 898
Posts 148950
Boards Moderated 0
Alias Born 08/13/2010

BottomBounce

Re: BigNexEnd post# 1482

Thursday, 01/17/2019 9:27:45 PM

Thursday, January 17, 2019 9:27:45 PM

Post# of 1721
Insys $INSY up 7% on FDA support for OTC naloxone

INSYS Therapeutics (INSY +5.1%) is up on below-average volume in apparent reaction to a statement from FDA Commissioner Scott Gottlieb, M.D. supporting over-the-counter access for opioid overdose med naloxone, currently prescription-only.

The agency has taken the added step of developing a model Drug Facts Label (DFL) to aid developers in their regulatory submissions. A DFL is a set of instructions for consumers detailing the safe use of the product without the supervision of a healthcare professional.

https://seekingalpha.com/news/3423915-insys-7-percent-fda-support-otc-naloxone

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up